ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cobanoglu, A.
Right arrow Articles by Starr, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cobanoglu, A.
Right arrow Articles by Starr, A.

The Annals of Thoracic Surgery, Vol 43, 245-253, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

A tri-institutional comparison of tissue and mechanical values using a patient-oriented definition of "treatment failure"

A Cobanoglu, WR Jamieson, DC Miller, C McKinley, GL Grunkemeier, HS Floten, RT Miyagishima, GF Tyers, NE Shumway and A Starr

Selection of valve type for predominant usage is obscured by limiting the analysis to prosthesis-related rather than patient-oriented failure modes. In this report, "treatment failure" is defined as a valve- related death or permanent patient disability; successful reoperations are excluded, and emboli with permanent residua are included. Results with the Starr-Edwards Silastic ball valve (Oregon) and the Hancock (Stanford) and Carpentier-Edwards (Vancouver) porcine valves are compared using this new definition of treatment failure. Evaluated according to structural failure, the mechanical valve is superior to the tissue valve, and using the Stanford definition of valve failure, it becomes so between 5 and 10 years. Using treatment failure, tissue valves are superior at 5 years; at 10 years in the aortic position, the results are comparable; and in the mitral position at 8 to 10 years, tissue valves show a continued but small advantage.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. W. Akins, A. D. Hilgenberg, G. J. Vlahakes, T. E. MacGillivray, D. F. Torchiana, and J. C. Madsen
Results of bioprosthetic versus mechanical aortic valve replacement performed with concomitant coronary artery bypass grafting
Ann. Thorac. Surg., October 1, 2002; 74(4): 1098 - 1106.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y.-Y. Cen, D. D. Glower, K. Landolfo, J. E. Lowe, R. D. Davis, W. G. Wolfe, C. Pieper, and B. Peterson
Comparison of survival after mitral valve replacement with biologic and mechanical valves in 1139 patients
J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 569 - 577.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. W. Akins, M. J. Buckley, W. M. Daggett, A. D. Hilgenberg, G. J. Vlahakes, D. F. Torchiana, and J. C. Madsen
Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses
Ann. Thorac. Surg., June 1, 1998; 65(6): 1545 - 1551.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. E. Hammermeister, G. K. Sethi, W. G. Henderson, C. Oprian, T. Kim, S. Rahimtoola, and The Veterans Affairs Cooperative Study on Valvular
A Comparison of Outcomes in Men 11 Years after Heart-Valve Replacement with a Mechanical Valve or Bioprosthesis
N. Engl. J. Med., May 6, 1993; 328(18): 1289 - 1296.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.